维生素C不影响脓毒症患者的血小板计数:LOVIT随机试验的事后分析
该研究为LOVIT随机试验的事后分析,纳入ICU停留超过24小时、确诊或疑似感染、需要血管升压药且有血小板计数数据的患者。干预为维生素C 50 mg/kg体重每6小时一次共4天或安慰剂。863例中859例有血小板数据;血小板计数纵向轨迹与28天死亡率显著相关(每增加10×10^9/L,HR 0.97,95%CI 0.96-0.98),但维生素C对死亡率的影响与基线或随时间变化的血小板计数均无交互作用。结论不支持维生素C通过影响血小板计数增加脓毒症患者死亡风险的假说。
要点
- LOVIT试验事后分析中,维生素C 50 mg/kg每6小时用4天对脓毒症患者28天死亡率的影响与基线血小板计数无交互作用。
- 维生素C对28天死亡率的影响与随时间变化的血小板计数轨迹也无交互作用。
- 血小板计数纵向轨迹与28天死亡率显著相关:每增加10×10^9/L,HR 0.97(95%CI 0.96-0.98)。
- 859例有血小板数据的患者中,未发现维生素C通过改变血小板计数影响死亡风险的证据。
- 作者结论:结果不支持维生素C通过影响血小板计数增加脓毒症患者死亡风险的假说。
适用人群与场景
- ICU停留超过24小时、确诊或疑似感染、需要血管升压药且有血小板计数数据的脓毒症患者(LOVIT试验纳入人群)。
处置流程与药物剂量
- 维生素C 50 mg/kg体重,每6小时一次,持续4天,或安慰剂(LOVIT试验干预方案)。
研究设计与关键结果
- 研究类型:LOVIT随机试验的事后分析,多中心国际研究;863例纳入LOVIT试验,859例有任何时间点的血小板计数数据。
- 主要结果:血小板计数纵向轨迹与28天死亡率显著相关(每增加10×10^9/L,HR 0.97,95%CI 0.96-0.98)。
- 维生素C对死亡率的影响与基线血小板计数无交互作用,与随时间变化的血小板计数也无交互作用。
证据类型、等级与局限
- 证据类型:随机试验(LOVIT)的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,结果不支持维生素C通过影响血小板计数增加脓毒症患者死亡风险的假说。
指南或共识出处
- LOVIT随机试验(clinicaltrials.gov NCT03680274)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Vitamin C has been linked to alterations in platelet count and aggregation behavior. Given recent findings suggesting an association between vitamin C and adverse outcomes in patients with septic shock, we aimed to investigate whether vitamin C influences mortality in septic patients through its impact on platelets.
DESIGN: Post hoc analysis of the Lessening Organ Dysfunction With Vitamin C (LOVIT) randomized trial (clinicaltrials.gov NCT03680274).
SETTING: Multicenter international study.
PATIENTS: Patients were included with an ICU stay of more than 24 hours, confirmed or suspected infection, vasopressor requirement, and availability of platelet count data.
INTERVENTION: Vitamin C (50 mg/kg body weight) every 6 hours for 4 days, or placebo.
MEASUREMENTS AND MAIN RESULTS: Of the 863 patients enrolled in the LOVIT trial, 859 had available platelet count data at any time. Although the longitudinal trajectory of platelet count was significantly associated with 28-day mortality (hazard ratio 0.97 per 10 × 109/L increase, 95% CI, 0.96-0.98), there was no interaction between the effect of vitamin C on mortality and either platelet count at baseline or over time.
CONCLUSIONS: These results do not support the hypothesis that vitamin C administration increases mortality risk by affecting platelet count.
参考来源
- Müller MM, Pinto R, Lamontagne F, et al. Vitamin C Does Not Affect Platelet Counts in Patients With Sepsis: A Post hoc Analysis of the Lessening Organ Dysfunction With Vitamin C Randomized Trial. Crit Care Explor. 2025. PMID: 40927646. doi:10.1097/CCE.0000000000001310
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。